Natixis’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-11,500
Closed -$276K 1007
2023
Q1
$276K Buy
+11,500
New +$276K ﹤0.01% 695